Adaptive Biotechnologies Corp (ADPT)
$26.64 -5.43% Close Oct 30, 2026 Live
Adaptive Biotechnologies stock today
Adaptive Biotechnologies closed at $26.64 on October 30, 2026, down 5.43% on the day. Over the past year it returned +57.5% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $4.26 billion.
$20.00$30.00
NovJan 2026MarMayJulSep
| Period | ADPT | S&P 500 (SPY) |
|---|---|---|
| 1 month | -7.8% | -0.9% |
| 3 months | +10.2% | +2.1% |
| Year to date | +64.0% | +11.7% |
| 1 year | +57.5% | +12.4% |
| 3 years | +515.2% | +88.5% |
| 5 years | -20.3% | +76.0% |
Key statistics
- Market value
- $4.26B
- Price / sales
- 13.8
- 52-week range
- $12.41 to $29.84
- Next report
- Nov 4, 2026
About Adaptive Biotechnologies
Develops T-cell therapy and adaptive immune response diagnostics.
Sector: Health Care
More on Adaptive Biotechnologies
- Financials: revenue, earnings and segmentsRevenue +55% in the year to Dec 2025
- Returns: what $1,000 became$1,000 five years ago is $797.37 today
No forecast, no recommendation. This page describes Adaptive Biotechnologies Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.